These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38437986)

  • 1. Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study.
    Plachy L; Neuman V; Velichova K; Slavenko MG; Santova A; Anne Amaratunga S; Obermannova B; Kolouskova S; Pruhova S; Sumnik Z; Petruzelkova L
    Diabetes Res Clin Pract; 2024 Mar; 209():111602. PubMed ID: 38437986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA
    Ruiz de Adana MS; Alhambra-Expósito MR; Muñoz-Garach A; Gonzalez-Molero I; Colomo N; Torres-Barea I; Aguilar-Diosdado M; Carral F; Serrano M; Martínez-Brocca MA; Duran A; Palomares R;
    Diabetes Care; 2020 Feb; 43(2):337-342. PubMed ID: 31831473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial.
    Ruissen MM; Torres-Peña JD; Uitbeijerse BS; Arenas de Larriva AP; Huisman SD; Namli T; Salzsieder E; Vogt L; Ploessnig M; van der Putte B; Merle A; Serra G; Rodríguez G; de Graaf AA; de Koning EJP; Delgado-Lista J; Sont JK;
    Diabetologia; 2023 Dec; 66(12):2213-2225. PubMed ID: 37775611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monthly Video-Consultation for Children With Type 1 Diabetes Using a Continuous Glucose Monitoring System: Design of ViDiKi, a Multimethod Intervention Study to Evaluate the Benefit of Telemedicine.
    Frielitz FS; Müller-Godeffroy E; Hübner J; Eisemann N; Dördelmann J; Menrath I; Katalinic A; Hiort O; von Sengbusch S
    J Diabetes Sci Technol; 2020 Jan; 14(1):105-111. PubMed ID: 31315446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
    Di Molfetta S; Patruno P; Cormio S; Cignarelli A; Paleari R; Mosca A; Lamacchia O; De Cosmo S; Massa M; Natalicchio A; Perrini S; Laviola L; Giorgino F
    J Endocrinol Invest; 2022 Sep; 45(9):1663-1671. PubMed ID: 35476320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study.
    Esmatjes E; Jansà M; Roca D; Pérez-Ferre N; del Valle L; Martínez-Hervás S; Ruiz de Adana M; Linares F; Batanero R; Vázquez F; Gomis R; de Solà-Morales O;
    Diabetes Technol Ther; 2014 Jul; 16(7):435-41. PubMed ID: 24528195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial.
    Laurberg T; Schougaard LMV; Hjollund NHI; Lomborg KE; Hansen TK; Jensen AL
    Diabet Med; 2022 May; 39(5):e14791. PubMed ID: 35028992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Hemoglobin A1c Levels in the First Year After Diagnosis Among Youths With Type 1 Diabetes Offered Continuous Glucose Monitoring.
    Addala A; Ding V; Zaharieva DP; Bishop FK; Adams AS; King AC; Johari R; Scheinker D; Hood KK; Desai M; Maahs DM; Prahalad P;
    JAMA Netw Open; 2023 Apr; 6(4):e238881. PubMed ID: 37074715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme.
    Gaudillère M; Pollin-Javon C; Brunot S; Villar Fimbel S; Thivolet C
    Diabetes Metab; 2021 Nov; 47(6):101251. PubMed ID: 33862199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol.
    Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial.
    Mathiesen ER; Alibegovic AC; Corcoy R; Dunne F; Feig DS; Hod M; Jia T; Kalyanam B; Kar S; Kautzky-Willer A; Marchesini C; Rea RD; Damm P;
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):86-95. PubMed ID: 36623517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps.
    Yaron M; Sher B; Sorek D; Shomer M; Levek N; Schiller T; Gaspar M; Frumkin Ben-David R; Mazor-Aronovitch K; Tish E; Shapira Y; Pinhas-Hamiel O
    Acta Diabetol; 2019 Jun; 56(6):667-673. PubMed ID: 30783823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
    Battelino T; Danne T; Edelman SV; Choudhary P; Renard E; Westerbacka J; Mukherjee B; Pilorget V; Coudert M; Bergenstal RM
    Diabetes Obes Metab; 2023 Feb; 25(2):545-555. PubMed ID: 36263928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.